S. P. Eisenberg

Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.

R. Thompson, W. Arend, S. Eisenberg, 1990, The Journal of clinical investigation.

Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis.

W. Benjamin, J. Plocinski, K. Kaffka, 1991, Proceedings of the National Academy of Sciences of the United States of America.

An interleukin 1 beta point mutant demonstrates that jun/fos expression is not sufficient for fibroblast metalloproteinase expression.

S. Krane, S. Goldring, J. Dayer, 1991, The Journal of biological chemistry.

The human interleukin-1 receptor antagonist (IL1RN) gene is located in the chromosome 2q14 region.

D. Patterson, W. Arend, I. Hart, 1993, Genomics.

IL-1ra ELISA: reduction and alkylation of synovial fluid eliminates interference by IgM rheumatoid factors.

W. Arend, S. P. Eisenberg, M. Malyak, 1991, Journal of immunological methods.

Human IL-1 receptor antagonist promoter. Cell type-specific activity and identification of regulatory regions.

M. T. Brewer, A. Gutierrez-Hartmann, W. Arend, 1992, Journal of immunology.

Production and characterization of human basic fibroblast growth factor from Escherichia coli.

A. Sommer, S. Eisenberg, P. Polverini, 1988, The Journal of biological chemistry.